ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,079Medicare Part D Prescriptions Filled, Including Refills

Rank: 372 out of 2061

$754K Total Retail Price of All Prescriptions

Rank: 291 out of 2061

506 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 506 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 506 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 9,439 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LEVOTHYROXINE SODIUM 530 489 1 3
LISINOPRIL 353 325 2 2
SIMVASTATIN 308 273 3 1
AMLODIPINE BESYLATE 308 264 3 4
FUROSEMIDE 301 273 5 6
ATORVASTATIN CALCIUM 288 260 6 8
WARFARIN SODIUM 275 265 7 11
OMEPRAZOLE 273 237 8 5
CARVEDILOL 251 214 9 22
ATENOLOL 229 209 10 13
DIOVAN 224 184 11 41
HYDROCODONE-ACETAMINOPHEN 208 163 S3 12 10
PRAVASTATIN SODIUM 175 161 13 14
METFORMIN HCL 170 159 14 9
CRESTOR 166 139 15 31
HYDROCHLOROTHIAZIDE 163 150 16 12
METOPROLOL TARTRATE 158 137 17 7
CITALOPRAM HBR 153 139 18 20
PREDNISONE 143 130 19 32
DONEPEZIL HCL 131 131 20 24
FLUTICASONE PROPIONATE 119 94 21 43
ALENDRONATE SODIUM 112 102 22 25
FENOFIBRATE 104 93 23 65
TRAZODONE HCL 99 54 24 39
POTASSIUM CHLORIDE 99 98 24 16
GABAPENTIN 94 47 26 15
KLOR-CON M20 93 69 27 47
TRAMADOL HCL 91 59 28 18
JANUVIA 90 90 29 51
ALLOPURINOL 88 74 30 28
AZITHROMYCIN 88 75 30 34
LOSARTAN POTASSIUM 87 84 32 17
CLARITHROMYCIN 82 71 33 390
ISOSORBIDE MONONITRATE ER 81 81 34 42
GLYBURIDE 77 53 R 35 60
LEVOFLOXACIN 74 61 36 111
NAMENDA 73 73 37 37
NIFEDIPINE ER 71 70 38 134
ZOLPIDEM TARTRATE 69 56 39 23
DIGOXIN 69 53 39 56
NEXIUM 65 41 41 26
FENTANYL 61 50 S2 42 84
AMLODIPINE BESYLATE-BENAZEPRIL 61 46 42 79
SERTRALINE HCL 61 28 42 21
DILTIAZEM 24HR ER 60 43 45 108
METOPROLOL SUCCINATE 58 58 46 19
LOVASTATIN 58 58 46 35
LANTUS 57 48 48 48
TAMSULOSIN HCL 56 56 49 30
MELOXICAM 55 50 50 44
SYNTHROID 54 51 51 58
LIPITOR 53 40 52 70
TRIAMTERENE-HYDROCHLOROTHIAZID 51 39 53 135
ALPRAZOLAM 50 45 54 85
CLONIDINE HCL 50 42 54 52
CYCLOBENZAPRINE HCL 50 16 R 54 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 31, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.